# Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

> **NCT06926491** · PHASE3 · RECRUITING · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Achondroplasia

## Interventions

- **DRUG:** KK8398

## Key facts

- **NCT ID:** NCT06926491
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2029-05-31
- **Final completion:** 2031-05-31
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926491, "Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06926491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*